The Plantation, Florida, corporation has also temporarily shuttered 17 of its freestanding imaging centers, while also working out new payment schedules with landlords and vendors.
Omecamtiv mecarbil, a cardiac myosin activator being manufactured by Amgen and Cytokinetics to treat heart failure with reduced ejection fraction, has been granted a Fast Track designation by the FDA.
Drinking just one sugary drink per day can increase a woman’s risk of cardiovascular disease (CVD) by 19%, according to new findings published in the Journal of the American Heart Association.
With further testing and validation, Hyungjin Kim, with Seoul’s National University College of Medicine and colleagues believe radiologists may one day use the tool to individualize treatment and achieve better outcomes.